Skip to main content
. 2017 Nov 6;8(68):113163–113173. doi: 10.18632/oncotarget.22635

Table 2. Associations between SOX9 expression and OS stratified according to the ethnics, case number, NOS score, follow-up time, antibody and cut-off value.

Categories Subgroups Ref HR (95% CI) Heterogeneity test (I2, P-value)
Ethnics Asian Not Asian [9, 10, 14, 16, 18, 19, 24, 32, 3436, 3840, 42] 1.98 (1.50–2.62) 53.8%, 0.009
1.19 (0.96–1.48) 60.7%, 0.111
Case Number ≥ 100 [13,41] 1.60 (1.29–1.99) 71.8%, 0.000
[9, 10, 18, 19, 24, 32, 34, 35, 38, 39, 42]
< 100 [13, 14, 16, 36,40, 41] 2.05 (1.30–3.23) 0.0%, 0.770
NOS Score ≥ 7 [9, 10, 18, 34, 38, 4042] 1.41 (1.10–1.79) 67.5%, 0.003
< 7 [13, 14, 16, 19, 24, 32, 35, 36, 39] 2.69 (1.99–3.62) 46.4%, 0.071
Follow-up Time ≥ 120 m [13, 16, 18, 19, 34, 35, 39] 2.26 (1.46–3.50) 78.0%, 0.001
< 120 m [9, 10, 14, 24, 32, 36, 38, 4042] 1.53 (1.23–1.91) 67.1%, 0.001
Antibody Santa Cruz [13, 14, 16, 18, 34, 35, 38, 41] 1.58 (1.28–1.95) 74.0%, 0.001
Millipore [10, 24, 32, 36, 42] 1.54 (0.92–2.59) 41.1%, 0.147
Abcam [9, 39] 3.54 (2.11–5.94) 0.0%, 0.749
Abnova [19, 40] 1.63 (0.94–2.83) 0.0%, 0.573
Cut-off Value IRS [9, 14, 16, 32, 35, 36, 38, 42] 2.64 (1.67–4.17) 30.3%, 0.197
PS [13, 18, 24, 34, 40] 1.47 (0.99–2.18) 0.0%, 0.760
Percentage [10, 41] 1.13 (0.92–1.38) 0.0%, 0.844
NR [19, 39] 2.08 (1.37–3.16) 0.0%, 0.366

m: month; PS: Percentage Score; IRS: Immunoreactive Score; NR: Not Reported.